Bicycle Therapeutics PLC (BCYC)
22.18
-0.18
(-0.80%)
USD |
NASDAQ |
May 16, 16:00
22.16
-0.02
(-0.11%)
After-Hours: 20:00
Bicycle Therapeutics Revenue (TTM): 41.61M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 41.61M |
| December 31, 2023 | 26.98M |
| September 30, 2023 | 24.83M |
| June 30, 2023 | 22.52M |
| March 31, 2023 | 15.50M |
| December 31, 2022 | 14.46M |
| September 30, 2022 | 15.05M |
| June 30, 2022 | 16.34M |
| March 31, 2022 | 13.75M |
| December 31, 2021 | 11.70M |
| September 30, 2021 | 11.77M |
| Date | Value |
|---|---|
| June 30, 2021 | 11.28M |
| March 31, 2021 | 11.07M |
| December 31, 2020 | 10.39M |
| September 30, 2020 | 11.82M |
| June 30, 2020 | 8.595M |
| March 31, 2020 | 8.546M |
| December 31, 2019 | 13.80M |
| September 30, 2019 | 9.577M |
| June 30, 2019 | 10.57M |
| March 31, 2019 | 10.71M |
| December 31, 2018 | 7.136M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
8.546M
Minimum
Mar 2020
41.61M
Maximum
Mar 2024
15.51M
Average
12.79M
Median
Revenue (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | 0.4761M |
| NuCana PLC | -- |
| TC BioPharm (Holdings) PLC | -- |
| Adaptimmune Therapeutics PLC | 60.28M |
| Verona Pharma PLC | -- |